{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:15:16Z","timestamp":1794921316404,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00007\/10"],"award-info":[{"award-number":["MC_UU_00007\/10"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["222060\/Z\/20\/Z -PIII031"],"award-info":[{"award-number":["222060\/Z\/20\/Z -PIII031"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Haemochromatosis-UK - Fernau Award 2024"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hereditary haemochromatosis is caused by pathogenic variants in the homoeostatic iron regulator gene\n                    <jats:italic>HFE<\/jats:italic>\n                    . Outcomes include liver cancer, cirrhosis and arthropathy, but penetrance is incomplete. Here, we use genetic data from &gt;400,000 subjects to determine the genetic risk across 29 regions of the British Isles and Ireland. Northwest Irish and Outer Hebrideans are at the highest risk (1\/54 \u2013 1\/62 carry the major risk genotype), Mainland Scots are also at increased risk (1\/117), declining to 1\/212 in Southern England. We also assessed the prevalence of clinically diagnosed haemochromatosis in &gt;63 million people in NHS England and identified 70,365 cases. White Irish individuals have the highest prevalence (3.7x white British). Among white British, prevalence varied 11-fold from 1\/1972 in parts of Kent to 1\/177 in Liverpool. Discrepancies between genetic risks and prevalences of clinical diagnoses for Birmingham, Cumbria, Northumberland and Durham suggest under-diagnosis in these regions. We show heightened genetic risk of haemochromatosis in people of Northwest Irish and Hebridean ancestry and suggest health-economic modelling of community screening should be targeted to these priority areas.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-65511-7","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:03:00Z","timestamp":1770112980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The landscape of hereditary haemochromatosis risk and diagnosis across the British Isles and Ireland"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4137-1495","authenticated-orcid":false,"given":"Shona M.","family":"Kerr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9986-5677","authenticated-orcid":false,"given":"Benjamin S.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-7796","authenticated-orcid":false,"given":"Gannie","family":"Tzoneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9921-4305","authenticated-orcid":false,"given":"Alan R.","family":"Shuldiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-4520","authenticated-orcid":false,"given":"Edmund","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5751-9178","authenticated-orcid":false,"given":"James F.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"65511_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0140-6736(23)00287-8","volume":"401","author":"PC Adams","year":"2023","unstructured":"Adams, P. C., Jeffrey, G. & Ryan, J. Haemochromatosis.  Lancet 401, 1811\u20131821 (2023).","journal-title":"Lancet"},{"key":"65511_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1079-9796(03)00133-5","volume":"31","author":"G Lucotte","year":"2003","unstructured":"Lucotte, G. & Dieterlen, F. A European allele map of the C282Y mutation of hemochromatosis: celtic versus Viking origin of the mutation?. Blood Cells Mol. Dis. 31, 262\u2013267 (2003).","journal-title":"Blood Cells Mol. Dis."},{"key":"65511_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ajpa.22937","volume":"160","author":"KM Heath","year":"2016","unstructured":"Heath, K. M., Axton, J. H., McCullough, J. M. & Harris, N. The evolutionary adaptation of the C282Y mutation to culture and climate during the European Neolithic. Am. J. Phys. Anthropol. 160, 86\u2013101 (2016).","journal-title":"Am. J. Phys. Anthropol."},{"key":"65511_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11845-008-0248-6","volume":"178","author":"L Kirk","year":"2009","unstructured":"Kirk, L. et al. Haemochromatosis gene frequency in a control and diabetic Irish population. Ir. J. Med Sci. 178, 39\u201342 (2009).","journal-title":"Ir. J. Med Sci."},{"key":"65511_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1399-0039.1998.tb03076.x","volume":"52","author":"S Murphy","year":"1998","unstructured":"Murphy, S. et al. High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population -implications for haemochromatosis. Tissue Antigens 52, 484\u2013488 (1998).","journal-title":"Tissue Antigens"},{"key":"65511_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1073\/pnas.1518445113","volume":"113","author":"LM Cassidy","year":"2016","unstructured":"Cassidy, L. M. et al. Neolithic and Bronze Age migration to Ireland and establishment of the insular Atlantic genome. Proc. Natl Acad. Sci. USA 113, 368\u2013373 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"65511_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0306-9877(02)00179-2","volume":"59","author":"S Moalem","year":"2002","unstructured":"Moalem, S., Percy, M. E., Kruck, T. P. & Gelbart, R. R. Epidemic pathogenic selection: an explanation for hereditary hemochromatosis?. Med Hypotheses 59, 325\u2013329 (2002).","journal-title":"Med Hypotheses"},{"key":"65511_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/jgh.13621","volume":"32","author":"CD Warne","year":"2017","unstructured":"Warne, C. D. et al. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women. J. Gastroenterol. Hepatol. 32, 797\u2013802 (2017).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"65511_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0140-6736(02)07447-0","volume":"359,","author":"E Beutler","year":"2002","unstructured":"Beutler, E., Felitti, V. J., Koziol, J. A., Ho, N. J. & Gelbart, T. Penetrance of 845G-> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359, 211\u2013218 (2002).","journal-title":"Lancet"},{"key":"65511_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf4428","volume":"16","author":"NE Allen","year":"2024","unstructured":"Allen, N. E. et al. Prospective study design and data analysis in UK Biobank. Sci. Transl. Med 16, eadf4428 (2024).","journal-title":"Sci. Transl. Med"},{"key":"65511_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-081926","volume":"14","author":"MR Lucas","year":"2024","unstructured":"Lucas, M. R., Atkins, J. L., Pilling, L. C., Shearman, J. D. & Melzer, D. HFE genotypes, haemochromatosis diagnosis and clinical outcomes at age 80 years: a prospective cohort study in the UK Biobank. BMJ Open 14, e081926 (2024).","journal-title":"BMJ Open"},{"key":"65511_CR12","doi-asserted-by":"publisher","first-page":"k5222","DOI":"10.1136\/bmj.k5222","volume":"364","author":"LC Pilling","year":"2019","unstructured":"Pilling, L. C. et al. Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank. BMJ 364, k5222 (2019).","journal-title":"BMJ"},{"key":"65511_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jhep.2014.10.025","volume":"62","author":"E Bardou-Jacquet","year":"2015","unstructured":"Bardou-Jacquet, E. et al. Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis. J. Hepatol. 62, 682\u2013689 (2015).","journal-title":"J. Hepatol."},{"key":"65511_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/gim.2017.121","volume":"20","author":"SD Grosse","year":"2018","unstructured":"Grosse, S. D., Gurrin, L. C., Bertalli, N. A. & Allen, K. J. Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes. Genet Med 20, 383\u2013389 (2018).","journal-title":"Genet Med"},{"key":"65511_CR15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","volume":"23","author":"DT Miller","year":"2021","unstructured":"Miller, D. T. et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 23, 1381\u20131390 (2021).","journal-title":"Genet Med"},{"key":"65511_CR16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1053\/gast.1996.v110.pm8613000","volume":"110","author":"C Niederau","year":"1996","unstructured":"Niederau, C. et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110, 1107\u20131119 (1996).","journal-title":"Gastroenterology"},{"key":"65511_CR17","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1056\/NEJMoa041534","volume":"352","author":"PC Adams","year":"2005","unstructured":"Adams, P. C. et al. Hemochromatosis and iron-overload screening in a racially diverse population. N. Engl. J. Med 352, 1769\u20131778 (2005).","journal-title":"N. Engl. J. Med"},{"key":"65511_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s42003-023-05708-y","volume":"7","author":"E Venner","year":"2024","unstructured":"Venner, E. et al. The frequency of pathogenic variation in the All of Us cohort reveals ancestry-driven disparities. Commun. Biol. 7, 174 (2024).","journal-title":"Commun. Biol."},{"key":"65511_CR19","doi-asserted-by":"crossref","unstructured":"Landrum, M. J. et al. ClinVar: updates to support classifications of both germline and somatic variants. Nucleic Acids Res. 53, D1313-D1321 (2024).","DOI":"10.1093\/nar\/gkae1090"},{"key":"65511_CR20","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/ajh.24535","volume":"91","author":"H Hamdi-Roze","year":"2016","unstructured":"Hamdi-Roze, H. et al. Rare HFE variants are the most frequent cause of hemochromatosis in non-c282y homozygous patients with hemochromatosis. Am. J. Hematol. 91, 1202\u20131205 (2016).","journal-title":"Am. J. Hematol."},{"key":"65511_CR21","doi-asserted-by":"publisher","first-page":"e2338995","DOI":"10.1001\/jamanetworkopen.2023.38995","volume":"6","author":"JM Savatt","year":"2023","unstructured":"Savatt, J. M. et al. Testing and management of iron overload after genetic screening-identified hemochromatosis. JAMA Netw. Open 6, e2338995 (2023).","journal-title":"JAMA Netw. Open"},{"key":"65511_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22603-9","volume":"25","author":"GL Samms","year":"2025","unstructured":"Samms, G. L. & Ponting, C. P. Unequal access to diagnosis of myalgic encephalomyelitis in England. BMC Public Health 25, 1417 (2025).","journal-title":"BMC Public Health"},{"key":"65511_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ajhg.2025.02.018","volume":"112","author":"SM Kerr","year":"2025","unstructured":"Kerr, S. M. et al. Actionable genetic variants in 4,198 Scottish participants from the Orkney and Shetland founder populations and implementation of return of results. Am. J. Hum. Genet 112, 793\u2013807 (2025).","journal-title":"Am. J. Hum. Genet"},{"key":"65511_CR24","doi-asserted-by":"publisher","first-page":"19064","DOI":"10.1073\/pnas.1904761116","volume":"116","author":"E Gilbert","year":"2019","unstructured":"Gilbert, E. et al. The genetic landscape of Scotland and the Isles. Proc. Natl Acad. Sci. USA 116, 19064\u201319070 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"65511_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature14230","volume":"519","author":"S Leslie","year":"2015","unstructured":"Leslie, S. et al. The fine-scale genetic structure of the British population. Nature 519, 309\u2013314 (2015).","journal-title":"Nature"},{"key":"65511_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-022-05247-2","volume":"610","author":"J Gretzinger","year":"2022","unstructured":"Gretzinger, J. et al. The Anglo-Saxon migration and the formation of the early English gene pool. Nature 610, 112\u2013119 (2022).","journal-title":"Nature"},{"key":"65511_CR27","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry, A. et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am. J. Epidemiol. 186, 1026\u20131034 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"65511_CR28","unstructured":"Moustarah, F. & Daley, S. F. Dietary Iron. in StatPearls (Treasure Island (FL), StatPearls Publishing, 2025)."},{"key":"65511_CR29","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1161\/ATVBAHA.122.317664","volume":"42","author":"P Timmers","year":"2022","unstructured":"Timmers, P. & Wilson, J. F. Limited effect of Y chromosome variation on coronary artery disease and mortality in UK Biobank-Brief Report. Arterioscler. Thromb. Vasc. Biol. 42, 1198\u20131206 (2022).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"65511_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s41669-023-00463-6","volume":"8","author":"M Hoxha","year":"2024","unstructured":"Hoxha, M., Malaj, V. & Zappacosta, B. Health economic evaluations of hemochromatosis screening and treatment: a systematic review. Pharmacoecon. Open 8, 147\u2013170 (2024).","journal-title":"Pharmacoecon. Open"},{"key":"65511_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/ijlh.12347","volume":"37","author":"PC Adams","year":"2015","unstructured":"Adams, P. C. Epidemiology and diagnostic testing for hemochromatosis and iron overload. Int. J. Lab. Hematol. 37, 25\u201330 (2015).","journal-title":"Int. J. Lab. Hematol."},{"key":"65511_CR32","doi-asserted-by":"crossref","unstructured":"Schmidtke, J. Twenty-five years of contemplating genotype-based hereditary hemochromatosis population screening. Genes 13, 162 (2022).","DOI":"10.3390\/genes13091622"},{"key":"65511_CR33","doi-asserted-by":"crossref","unstructured":"Delatycki, M. B. & Allen, K. J. Population screening for hereditary haemochromatosis-should it be carried out, and if so, how? Genes 15, 967 (2024).","DOI":"10.3390\/genes15080967"},{"key":"65511_CR34","first-page":"2121","volume":"8","author":"S Kerr","year":"2023","unstructured":"Kerr, S. et al. VIKING II, a worldwide observational cohort of volunteers with Northern Isles Ancestry. Int. J. Popul Data Sci. 8, 2121 (2023).","journal-title":"Int. J. Popul Data Sci."},{"key":"65511_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ajhg.2008.08.007","volume":"83","author":"R McQuillan","year":"2008","unstructured":"McQuillan, R. et al. Runs of homozygosity in European populations. Am. J. Hum. Genet 83, 359\u2013372 (2008).","journal-title":"Am. J. Hum. Genet"},{"key":"65511_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47436-6","volume":"9","author":"SM Kerr","year":"2019","unstructured":"Kerr, S. M. et al. An actionable KCNH2 Long QT Syndrome variant detected by sequence and haplotype analysis in a population research cohort. Sci. Rep. 9, 10964 (2019).","journal-title":"Sci. Rep."},{"key":"65511_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"65511_CR38","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41431-024-01704-w","volume":"32","author":"SM Kerr","year":"2024","unstructured":"Kerr, S. M. et al. Two founder variants account for over 90% of pathogenic BRCA alleles in Orkney and Shetland. Eur. J. Hum. Genet. 32, 1624\u20131631 (2024).","journal-title":"Eur. J. Hum. Genet."},{"key":"65511_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51604-2","volume":"15","author":"M Halachev","year":"2024","unstructured":"Halachev, M. et al. Regionally enriched rare deleterious exonic variants in the UK and Ireland. Nat. Commun. 15, 8454 (2024).","journal-title":"Nat. Commun."},{"key":"65511_CR40","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41431-023-01297-w","volume":"31","author":"SM Kerr","year":"2023","unstructured":"Kerr, S. M. et al. Clinical case study meets population cohort: identification of a BRCA1 pathogenic founder variant in Orcadians. Eur. J. Hum. Genet. 31, 588\u2013595 (2023).","journal-title":"Eur. J. Hum. Genet."},{"key":"65511_CR41","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41586-020-2853-0","volume":"586","author":"CV Van Hout","year":"2020","unstructured":"Van Hout, C. V. et al. Exome sequencing and characterization of 49,960 individuals in the UK Biobank. Nature 586, 749\u2013756 (2020).","journal-title":"Nature"},{"key":"65511_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).","journal-title":"Gigascience"},{"key":"65511_CR43","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867\u20132873 (2010).","journal-title":"Bioinformatics"},{"key":"65511_CR44","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3679","volume":"48","author":"PR Loh","year":"2016","unstructured":"Loh, P. R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet. 48, 1443\u20131448 (2016).","journal-title":"Nat. Genet."},{"key":"65511_CR45","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ajhg.2020.02.010","volume":"106","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y., Browning, S. R. & Browning, B. L. A fast and simple method for detecting identity-by-descent segments in large-scale data. Am. J. Hum. Genet. 106, 426\u2013437 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"65511_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41695-z","volume":"9","author":"VA Traag","year":"2019","unstructured":"Traag, V. A., Waltman, L. & van Eck, N. J. From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep. 9, 5233 (2019).","journal-title":"Sci. Rep."},{"key":"65511_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17124-4","volume":"7","author":"E Gilbert","year":"2017","unstructured":"Gilbert, E. et al. The Irish DNA Atlas: revealing fine-scale population structure and history within Ireland. Sci. Rep. 7, 17199 (2017).","journal-title":"Sci. Rep."},{"key":"65511_CR48","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1073\/pnas.1219885110","volume":"110","author":"KC Desch","year":"2013","unstructured":"Desch, K. C. et al. Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association. Proc. Natl Acad. Sci. USA 110, 588\u2013593 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65511-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65511-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65511-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:03:02Z","timestamp":1770112982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65511-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["65511"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65511-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.R.S. and G.T. are employees and stock and stock option holders of Regeneron Pharmaceuticals, Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"716"}}